MoonLake Immunotherapeutics

MLTX ·Healthcare, Drug Manufacturers - General, Switzerland
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 30, 2026 CURRENT REPORT
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
S-8 Aug 10, 2026 REGISTRATION STATEMENT
S-3ASR Aug 10, 2026 REGISTRATION STATEMENT
10-Q Aug 10, 2026 10-Q
8-K Aug 10, 2026 CURRENT REPORT
4 Jul 29, 2026
4 Jul 23, 2026
4 Jul 21, 2026
4 Jul 20, 2026
144 Jul 15, 2026
8-K Jul 15, 2026 CURRENT REPORT
4 Jul 13, 2026
4 Jul 2, 2026
144 Jun 30, 2026
SCHEDULE 13D/A Jun 29, 2026
8-K Jun 25, 2026 CURRENT REPORT
424B5 Jun 24, 2026 PROSPECTUS SUPPLEMENT
4 Jun 23, 2026
424B5 Jun 22, 2026 PRELIMINARY PROSPECTUS SUPPLEMENT
4 Jun 22, 2026 OWNERSHIP DOCUMENT
8-K Jun 22, 2026 CURRENT REPORT
4 Jun 18, 2026
← Newer Page 1 of 14 · 329 filings Older →